Saturday 17 October 2026 Export AXSM’s income statement to Excel — free account

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $638.5 million, up 65.5% from fiscal 2024. In the quarter to June 2026, revenue grew 45.5%, EPS fell 2.06%, free cash flow fell 2.98% and total debt rose 4.66%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

157.14 4.65 −2.87%

Follow AXSM

Alert me

Market cap: $8.5B
P/E: 0.0×
Fwd P/E: −121×
Dividend yield: —
F-score: 5/9
Altman Z: 6.91
Beneish M: −2.53
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		10.82	14.23	12.22	16.33
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		5,808.00	(487.10)	(418.04)	(384.77)
P/B ratio Full definition →		82.40	102.90	158.53	152.20
Price to Tangible BV Full definition →		310.61	254.26	2,405.15	373.97
EV/Sales Full definition →		10.46	13.92	11.96	16.08
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(58.17)	(95.13)	(119.79)	(175.23)
EV/FCF Full definition →		(57.92)	(94.64)	(119.35)	(173.53)
Quick Ratio Full definition →		1.45	1.44	1.27	1.30
Current Ratio Full definition →		1.57	1.55	1.39	1.43
Net Debt/EBITDA Full definition →		4.66	8.20	2.98	4.14
Debt/Assets Full definition →		18.28%	17.68%	17.33%	16.68%
Debt/Equity Full definition →		1.66	1.38	2.27	1.52
Asset Turnover Full definition →		0.91	1.01	1.08	1.11
Operating CF/Net income Full definition →		(0.02)	0.65	0.32	0.64
Capex/Depreciation Full definition →		(0.02)	(0.03)	(0.05)	(0.15)
Interest Coverage Full definition →		(41.17)	(23.00)	(53.47)	(32.24)
Research and Development Expense of Revenue Full definition →		23.49%	24.89%	27.55%	21.17%
Selling, General and Administrative Expense of Revenue Full definition →		87.86%	86.38%	96.75%	95.31%
Intangible Assets out of Total Assets Full definition →		0.08	0.08	0.07	0.06
Share Based Compensation of Revenue Full definition →		13.51%	11.60%	12.26%	12.43%
Graham Net Nets Full definition →		0.00	0.00	(0.01)	0.00
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(3.85%)	(2.02%)	(2.21%)	(1.53%)
Free Cash Flow Yield Full definition →		(1.67%)	(1.03%)	(0.82%)	(0.57%)
Revenue per Share Full definition →		3.42	3.94	3.73	4.22
Operating CF per Share Full definition →		0.02	(0.37)	(0.40)	(0.64)
Capex per Share Full definition →		0.00	0.00	0.00	(0.01)
Free Cash Flow per Share Full definition →		0.02	(0.38)	(0.41)	(0.64)
Cash per Share Full definition →		6.50	6.49	5.96	6.17
Shareholders Equity per Share Full definition →		1.47	1.77	1.07	1.61
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.47	1.77	1.07	1.61
Free Cash Flow Full definition →		0.99	(18.72)	(20.82)	(33.40)
Working Capital Full definition →		205.05	210.15	172.00	196.12
Capital Expenditures Full definition →		(0.06)	(0.07)	(0.12)	(0.45)
Net Current Asset Value Full definition →		(30.18)	(12.52)	(47.81)	(21.57)
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		160.30	183.23	206.23	238.14
Average Payables Full definition →		59.24	68.77	96.18	85.30
Average Inventory Full definition →		19.02	21.84	23.92	28.16
Average Assets Full definition →		615.35	629.15	655.14	700.62
Average Common Equity Full definition →		83.31	72.65	53.90	78.19

Fold the line items

Columns are period end dates

Stockrow Weekly